This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Foundation Medicine, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Rachel Erbach and Cancer-Related Patent Innovation.
Introduction
Rachel Erbach is associated with Foundation Medicine, Inc., in Cambridge, Massachusetts. Her patent work concerns NTRK fusion molecules and their potential applications in cancer evaluation and treatment.
Latest Patents
Erbach is listed as an inventor on 1 patent, titled “NTRK Fusion Molecules and Uses Thereof.” The patent describes NTRK fusion molecules and detection reagents, along with methods and kits for evaluating, identifying, or assessing a subject with cancer and supporting treatment decisions.
Career Highlights
Erbach’s listed patent reflects work in cancer-related molecular diagnostics and the development of tools that may help characterize tumors and inform clinical care. The available information identifies her as affiliated with Foundation Medicine, Inc.
Collaborations
The patent lists Christopher Darcy and Anthony Classon among Erbach’s coworkers.
Conclusion
Rachel Erbach’s patent activity highlights an innovation focused on NTRK fusion detection and its potential role in cancer assessment and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile